Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.
about
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Co-administration of resveratr ...... urring cardiovascular changes.
@en
Co-administration of resveratr ...... urring cardiovascular changes.
@nl
type
label
Co-administration of resveratr ...... urring cardiovascular changes.
@en
Co-administration of resveratr ...... urring cardiovascular changes.
@nl
prefLabel
Co-administration of resveratr ...... urring cardiovascular changes.
@en
Co-administration of resveratr ...... urring cardiovascular changes.
@nl
P2093
P2860
P356
P1476
Co-administration of resveratr ...... curring cardiovascular changes
@en
P2093
Alessandro Bartolomucci
Carrie-Lynn M Soltys
Donna L Beker
Ian M Robertson
Jason R B Dyck
Maria Razzoli
Marianne K Grant
Nirmal Parajuli
Nobutoshi Matsumura
Shereen M Hamza
P2860
P304
P356
10.1093/CVR/CVY064
P577
2018-08-01T00:00:00Z